News
USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...
A recent research presented at the ENDO 2025 revealed that high blood sugar levels can impact men's sexual health. The ...
As Healio previously reported, the FDA announced Oct. 2 that tirzepatide (Mounjaro/Zepbound, Eli Lilly) had been removed from its drug shortage list after it confirmed with Eli Lilly that News News ...
Tirzepatide and semaglutide are highly effective medications for obesity management. The efficacy and safety of tirzepatide as compared with semaglutide in adults with obesity but without type 2 di ...
Tirzepatide also significantly reduced the onset of T2D, with only 1.3% of participants in the treatment groups developing T2D compared to 13.3% in the placebo group (hazard ratio = 0.07, P < 0.001).
A three-year study of tirzepatide – a medication approved in the US as Mounjaro for diabetes and Zepbound for weight loss – found that when adults who had prediabetes and obesity or overweight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results